A detailed history of Larson Financial Group LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 386 shares of ADMA stock, worth $6,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares
386
Previous 398 3.02%
Holding current value
$6,006
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$14.66 - $19.91 $175 - $238
-12 Reduced 3.02%
386 $5,000
Q2 2025

Aug 08, 2025

BUY
$17.6 - $24.51 $7,004 - $9,754
398 New
398 $7,000
Q3 2024

Nov 12, 2024

BUY
$11.21 - $20.03 $17,117 - $30,585
1,527 New
1,527 $30,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.